Payment overview · 2025
General Payments
1 reported records · 1 companies
Healthcare provider profile · identity verified
Allopathic & Osteopathic Physicians|Hospitalist · SHERMAN OAKS, CA · NPI 1144502618
Verified facts
CMS Open Payments records show Jigar Kadakia, M.D. received $21.17 in general payments during 2025 across 1 reported records.
Otsuka America Pharmaceutical, Inc. accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Payment overview · 2025
1 reported records · 1 companies
Separate record types
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. | Unresolved — no canonical attribution shown | $21.17 | 100.0% | 1 | 2025 |
What were the payments for?
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $21.17 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| REXULTI Normalized: rexulti |
Drug | Otsuka America Pharmaceutical, Inc. | $21.17 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 756 | 141 |
| Eliquis | Apixaban | 665 | 67 |
| Amlodipine Besylate | Amlodipine Besylate | 427 | 80 |
| Famotidine | Famotidine | 422 | 63 |
| Levothyroxine Sodium | Levothyroxine Sodium | 323 | 48 |
| Furosemide | Furosemide | 281 | 65 |
| Metoprolol Tartrate | Metoprolol Tartrate | 275 | 57 |
| Pantoprazole Sodium | Pantoprazole Sodium | 266 | 62 |
| Losartan Potassium | Losartan Potassium | 246 | 49 |
| Gabapentin | Gabapentin | 243 | 53 |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 211 | 43 |
| Carvedilol | Carvedilol | 194 | 32 |
| Mirtazapine | Mirtazapine | 191 | 43 |
| Donepezil Hcl | Donepezil Hcl | 188 | 22 |
| Tamsulosin Hcl | Tamsulosin Hcl | 182 | 35 |
| Lisinopril | Lisinopril | 176 | 34 |
| Sodium Chloride | 0.9 % Sodium Chloride | 157 | 47 |
| Levetiracetam | Levetiracetam | 151 | 23 |
| Xarelto | Rivaroxaban | 151 | 12 |
| Hydralazine Hcl | Hydralazine Hcl | 149 | 34 |
| Memantine Hcl | Memantine Hcl | 140 | 17 |
| Santyl | Collagenase Clostridium Hist. | 138 | 49 |
| Quetiapine Fumarate | Quetiapine Fumarate | 136 | 28 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 128 | 48 |
| Januvia | Sitagliptin Phosphate | 120 | 15 |
| Ertapenem | Ertapenem Sodium | 119 | 26 |
| Omeprazole | Omeprazole | 118 | 30 |
| Metformin Hcl | Metformin Hcl | 114 | 31 |
| Potassium Chloride | Potassium Chloride | 99 | 29 |
| Sevelamer Carbonate | Sevelamer Carbonate | 96 | 14 |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 86 | 19 |
| Clopidogrel | Clopidogrel Bisulfate | 79 | 20 |
| Ondansetron Hcl | Ondansetron Hcl | 79 | 54 |
| Finasteride | Finasteride | 77 | 15 |
| Labetalol Hcl | Labetalol Hcl | 73 | 12 |
| Enoxaparin Sodium | Enoxaparin Sodium | 71 | 12 |
| Jardiance | Empagliflozin | 71 | 12 |
| Diltiazem Hcl | Diltiazem Hcl | 69 | suppressed |
| Divalproex Sodium | Divalproex Sodium | 69 | 13 |
| Metoprolol Succinate | Metoprolol Succinate | 66 | 15 |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 65 | suppressed |
| Latanoprost | Latanoprost | 65 | 15 |
| Montelukast Sodium | Montelukast Sodium | 65 | suppressed |
| Clobetasol Propionate | Clobetasol Propionate | 62 | 17 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 61 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 57 | 37 |
| Prednisone | Prednisone | 57 | 23 |
| Amiodarone Hcl | Amiodarone Hcl | 55 | suppressed |
| Megestrol Acetate | Megestrol Acetate | 55 | 19 |
| Olanzapine | Olanzapine | 55 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 54 | 13 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 53 | 16 |
| Lorazepam | Lorazepam | 52 | 23 |
| Albuterol Sulfate | Albuterol Sulfate | 49 | 18 |
| Allopurinol | Allopurinol | 49 | suppressed |
| Humalog | Insulin Lispro | 49 | suppressed |
| Lactulose | Lactulose | 49 | 15 |
| Midodrine Hcl | Midodrine Hcl | 49 | 16 |
| Sertraline Hcl | Sertraline Hcl | 49 | 16 |
| Simvastatin | Simvastatin | 49 | 11 |
| Insulin Syringe | Syringe-Needle,insulin,0.5 Ml | 48 | 11 |
| Risperidone | Risperidone | 48 | 11 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 48 | 13 |
| Valproic Acid | Valproic Acid (As Sodium Salt) | 48 | suppressed |
| Baclofen | Baclofen | 47 | suppressed |
| Monoject Insulin Syringe | Syringe-Needle,insulin,0.5 Ml | 46 | 15 |
| Levalbuterol Hcl | Levalbuterol Hcl | 45 | suppressed |
| Hydrochlorothiazide | Hydrochlorothiazide | 44 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 44 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 43 | 11 |
| Alendronate Sodium | Alendronate Sodium | 42 | suppressed |
| Chlorhexidine Gluconate | Chlorhexidine Gluconate | 41 | 12 |
| Duloxetine Hcl | Duloxetine Hcl | 40 | 12 |
| Fluticasone Propionate | Fluticasone Propionate | 40 | 12 |
| Novolin R | Insulin Regular, Human | 40 | suppressed |
| Novolog Flexpen | Insulin Aspart | 40 | suppressed |
| Ezetimibe | Ezetimibe | 39 | suppressed |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 38 | 18 |
| Enulose | Lactulose | 38 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 38 | suppressed |
| Spironolactone | Spironolactone | 38 | suppressed |
| Xifaxan | Rifaximin | 38 | suppressed |
| Bumetanide | Bumetanide | 37 | suppressed |
| Linzess | Linaclotide | 37 | suppressed |
| Tobramycin Sulfate | Tobramycin Sulfate | 37 | suppressed |
| Ceftriaxone | Ceftriaxone Sodium | 35 | 20 |
| Scopolamine | Scopolamine | 35 | suppressed |
| Ibuprofen | Ibuprofen | 34 | 13 |
| Lacosamide | Lacosamide | 34 | suppressed |
| Nifedipine Er | Nifedipine | 34 | suppressed |
| Atorvaliq | Atorvastatin Calcium | 33 | suppressed |
| Insulin Glargine-Yfgn | Insulin Glargine-Yfgn | 33 | 13 |
| Levofloxacin | Levofloxacin | 33 | 29 |
| Insulin Aspart Flexpen | Insulin Aspart | 32 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 32 | suppressed |
| Sucralfate | Sucralfate | 32 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 31 | 12 |
| Humulin R | Insulin Regular, Human | 31 | 11 |
| Trazodone Hcl | Trazodone Hcl | 31 | 11 |
| Phenytoin | Phenytoin | 30 | suppressed |
| Brimonidine Tartrate | Brimonidine Tartrate | 29 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 29 | 24 |
| Zolpidem Tartrate | Zolpidem Tartrate | 29 | suppressed |
| Citalopram Hbr | Citalopram Hydrobromide | 28 | suppressed |
| Epogen | Epoetin Alfa | 28 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 28 | suppressed |
| Timolol Maleate | Timolol Maleate | 28 | suppressed |
| Brilinta | Ticagrelor | 27 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 27 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 27 | suppressed |
| Digoxin | Digoxin | 27 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 27 | suppressed |
| Cephalexin | Cephalexin | 26 | 18 |
| Clonidine Hcl | Clonidine Hcl | 26 | 13 |
| Glycopyrrolate | Glycopyrrolate | 26 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 26 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 26 | 13 |
| Entresto | Sacubitril/Valsartan | 25 | suppressed |
| Spiriva Handihaler | Tiotropium Bromide | 25 | suppressed |
| Vancomycin Hcl | Vancomycin/Water For Inj (Peg) | 25 | suppressed |
| Creon | Lipase/Protease/Amylase | 24 | suppressed |
| Mupirocin | Mupirocin | 24 | 13 |
| Azithromycin | Azithromycin | 23 | 21 |
| Fluoxetine Hcl | Fluoxetine Hcl | 23 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 23 | suppressed |
| Trueplus Insulin Syringe | Syringe-Needle,insulin,0.5 Ml | 23 | suppressed |
| Dabigatran Etexilate | Dabigatran Etexilate Mesylate | 22 | suppressed |
| Escitalopram Oxalate | Escitalopram Oxalate | 22 | suppressed |
| Humulin N Kwikpen | Insulin Nph Human Isophane | 22 | suppressed |
| Myrbetriq | Mirabegron | 22 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 22 | 18 |
| Alprazolam | Alprazolam | 21 | suppressed |
| Glipizide | Glipizide | 21 | suppressed |
| Heparin Sodium | Heparin Sodium,porcine | 21 | suppressed |
| Nystatin | Nystatin | 21 | suppressed |
| Pradaxa | Dabigatran Etexilate Mesylate | 21 | suppressed |
| Tramadol Hcl | Tramadol Hcl | 21 | 15 |
| Vancomycin Hcl | Vancomycin Hcl | 21 | 12 |
| Biktarvy | Bictegrav/Emtricit/Tenofov Ala | 20 | suppressed |
| Calcium Acetate | Calcium Acetate | 20 | suppressed |
| Folic Acid | Folic Acid | 20 | suppressed |
| Glucagon Emergency Kit | Glucagon | 20 | 16 |
| Janumet | Sitagliptin Phos/Metformin Hcl | 20 | suppressed |
| Methadone Hcl | Methadone Hcl | 20 | suppressed |
| Sevelamer Hcl | Sevelamer Hcl | 20 | suppressed |
| Aripiprazole | Aripiprazole | 19 | suppressed |
| Benztropine Mesylate | Benztropine Mesylate | 19 | suppressed |
| Bisoprolol Fumarate | Bisoprolol Fumarate | 19 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 19 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 19 | suppressed |
| Humulin N | Insulin Nph Human Isophane | 19 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 19 | suppressed |
| Norliqva | Amlodipine Besylate | 19 | suppressed |
| Clonazepam | Clonazepam | 18 | suppressed |
| Fluvoxamine Maleate | Fluvoxamine Maleate | 18 | suppressed |
| Chlorpromazine Hcl | Chlorpromazine Hcl | 17 | suppressed |
| Econazole Nitrate | Econazole Nitrate | 17 | suppressed |
| Fenofibrate | Fenofibrate | 17 | suppressed |
| Isentress | Raltegravir Potassium | 17 | suppressed |
| Dexamethasone | Dexamethasone | 16 | 15 |
| Dorzolamide-Timolol | Dorzolamide/Timolol/Pf | 16 | suppressed |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 16 | suppressed |
| Ketoconazole | Ketoconazole | 16 | suppressed |
| Methimazole | Methimazole | 16 | suppressed |
| Nitroglycerin | Nitroglycerin | 16 | 11 |
| Sodium Chloride | Sodium Chloride Irrig Solution | 16 | suppressed |
| Tobramycin-Dexamethasone | Tobramycin/Dexamethasone | 16 | 12 |
| Zenpep | Lipase/Protease/Amylase | 16 | suppressed |
| Dextrose In Water | Dextrose 5 % In Water | 15 | suppressed |
| Dorzolamide-Timolol | Dorzolamide Hcl/Timolol Maleat | 15 | suppressed |
| Lidocaine | Lidocaine | 15 | suppressed |
| Nystatin-Triamcinolone | Nystatin/Triamcinolone Acet | 15 | suppressed |
| Permethrin | Permethrin | 15 | suppressed |
| Pravastatin Sodium | Pravastatin Sodium | 15 | suppressed |
| Telmisartan | Telmisartan | 15 | suppressed |
| Valsartan | Valsartan | 15 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 14 | suppressed |
| Fluconazole | Fluconazole | 14 | 11 |
| Arexvy | Rsvpref3 Antigen/As01e/Pf | 13 | 13 |
| Budesonide | Budesonide | 13 | suppressed |
| Cefepime Hcl | Cefepime Hcl | 13 | suppressed |
| Fludrocortisone Acetate | Fludrocortisone Acetate | 13 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 13 | suppressed |
| Ranolazine Er | Ranolazine | 13 | suppressed |
| Alphagan P | Brimonidine Tartrate | 12 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 12 | 11 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 12 | suppressed |
| Novolin N | Insulin Nph Human Isophane | 12 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 12 | suppressed |
| Bethanechol Chloride | Bethanechol Chloride | 11 | suppressed |
| Clotrimazole | Clotrimazole | 11 | suppressed |
| Dilt-Xr | Diltiazem Hcl | 11 | suppressed |
| Diltiazem 24hr Er (La) | Diltiazem Hcl | 11 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 11 | suppressed |
| Methocarbamol | Methocarbamol | 11 | suppressed |
| Novolin N Flexpen | Insulin Nph Human Isophane | 11 | suppressed |
| Paxlovid | Nirmatrelvir/Ritonavir | 11 | 11 |
| Ssd | Silver Sulfadiazine | 11 | suppressed |
Timeline
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $21.17 · 1 records | Otsuka America Pharmaceutical, Inc. | REXULTI | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error